Frontiers In Pharmacology

Frontiers In Pharmacology

药理学前沿

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Frontiers In Pharmacology》是由Frontiers Media S.A.出版社于2010年创办的英文国际期刊(ISSN: 1663-9812,E-ISSN: 1663-9812),该期刊长期致力于药学领域的创新研究,主要研究方向为PHARMACOLOGY & PHARMACY。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表药学领域等方向的原创性研究为核心(研究类文章占比70.07%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在2944篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Frontiers In Pharmacology审稿周期约为 14 Weeks 。该刊近年未被列入国际预警名单,年发文量约2944篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 2944 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 65 / 354

81.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 61 / 354

82.91%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.8 SJR:1.066 SNIP:0.999
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q1 41 / 272

85%

大类:Medicine 小类:Pharmacology Q1 76 / 313

75%

期刊发文

  • Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment

    Author: Zhou, Jiao; Shi, Shan; Qiu, Yeqing; Jin, Zhongwen; Yu, Wenyan; Xie, Rongzhi; Zhang, Hongyu

    Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1153565

  • Comprehensive analysis of the cuproptosis-related gene DLD across cancers: A potential prognostic and immunotherapeutic target

    Author: Yang, Weiguang; Guo, Qiang; Wu, Haiyang; Tong, Linjian; Xiao, Jian; Wang, Yulin; Liu, Rui; Xu, Lixia; Yan, Hua; Sun, Zhiming

    Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1111462

  • Potential therapeutic effects of Chinese meteria medica in mitigating drug-induced acute kidney injury

    Author: Li, Jun; Li, Tonglu; Li, Zongping; Song, Zhiyong; Gong, Xuezhong

    Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1153297

  • Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo

    Author: Li, Hongshan; Xi, Yingfei; Xin, Xin; Feng, Qin; Hu, Yiyang

    Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1148737

  • Myelin sheath injury and repairment after subarachnoid hemorrhage

    Author: Chen, Mao; Guo, Peiwen; Ru, Xufang; Chen, Yujie; Zuo, Shilun; Feng, Hua

    Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1145605

  • Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis

    Author: Zheng, Fang; Wang, Yeshu; Zhang, Qunfang; Chen, Qiuyuan; Liang, Chun-Ling; Liu, Huazhen; Qiu, Feifei; Chen, Yuchao; Huang, Haiding; Lu, Weihui; Dai, Zhenhua

    Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1145407

  • Immune cell death-related lncRNA signature as a predictive factor of clinical outcomes and immune checkpoints in gastric cancer

    Author: Zhang, Zeyu; Su, Duntao; Thakur, Abhimanyu; Zhang, Kui; Xia, Fada; Yan, Yuanliang

    Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1162995

  • Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer

    Author: Yang, Yuting; Guo, Yanlei; Luo, Hua; Wang, Menglei; Chen, Fang; Cui, Huawei; Chen, Ping; Yin, Zhujun; Li, Li; Dai, Ying; Zeng, Jin; Zhao, Junning

    Journal: FRONTIERS IN PHARMACOLOGY. 2023; Vol. 14, Issue , pp. -. DOI: 10.3389/fphar.2023.1164827